Quick Takeaways
- Celadon Partners SPV 24 filed SCHEDULE 13D/A for Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI).
- Disclosed ownership: 45%.
- Date of event: 19 Jan 2026.
Celadon Partners SPV 24 - 19 Jan 2026 SCHEDULE 13D/A Report for Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI)
- Filing Manager
- Celadon Partners SPV 24
- Reporting Manager
- Celadon Partners SPV 24
- Symbol
- SNTI
- Shares outstanding
- 30,025,160 shares
- Disclosed Ownership
- 13,511,322 shares
- Ownership
- 45%
- Form type
- SCHEDULE 13D/A
- Filing time
- 20 Jan 2026, 16:05:54 UTC
- Date of event
- 19 Jan 2026
- Previous filing
- 02 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Celadon Partners SPV 24 disclosed 45% ownership in Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI) on 19 Jan 2026."
What Changed
- Previous schedule filing date: 02 Sep 2025.
- Current filing was accepted on 20 Jan 2026, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Celadon Partners SPV 24 | 45% | 13,511,322 | 0 | 13,511,322 | /s/ John Cullinane | John Cullinane, Manager, Celadon Partners, LLC (as sole manager of Celadon Partners SPV 24) | 0002060465 |
| Celadon Partners, LLC | 45% | 13,511,322 | 0 | 13,511,322 | /s/ John Cullinane | John Cullinane, Manager |